Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 25 | 2022 | 542 | 3.860 |
Why?
|
| Genetic Vectors | 21 | 2022 | 680 | 3.420 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2017 | 143 | 1.530 |
Why?
|
| Osteoblasts | 6 | 2019 | 189 | 1.340 |
Why?
|
| Transduction, Genetic | 6 | 2021 | 210 | 1.290 |
Why?
|
| Nanopores | 1 | 2022 | 5 | 0.970 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1232 | 0.940 |
Why?
|
| Gene Expression | 4 | 2019 | 774 | 0.920 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 321 | 0.880 |
Why?
|
| Transgenes | 4 | 2021 | 150 | 0.870 |
Why?
|
| Gene Transfer Techniques | 8 | 2021 | 264 | 0.800 |
Why?
|
| Osteogenesis | 3 | 2017 | 119 | 0.760 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 64 | 0.730 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 99 | 0.710 |
Why?
|
| Genome | 2 | 2017 | 216 | 0.700 |
Why?
|
| CCCTC-Binding Factor | 1 | 2017 | 37 | 0.680 |
Why?
|
| Genetic Therapy | 11 | 2022 | 571 | 0.680 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 31 | 0.670 |
Why?
|
| Promoter Regions, Genetic | 6 | 2019 | 666 | 0.650 |
Why?
|
| Animals | 29 | 2022 | 17856 | 0.580 |
Why?
|
| Genes, Reporter | 4 | 2019 | 235 | 0.550 |
Why?
|
| Eukaryota | 1 | 2014 | 29 | 0.530 |
Why?
|
| Mice | 20 | 2021 | 9050 | 0.480 |
Why?
|
| Cell Line | 8 | 2019 | 1975 | 0.460 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 76 | 0.450 |
Why?
|
| Genomics | 1 | 2014 | 265 | 0.440 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 73 | 0.430 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1534 | 0.410 |
Why?
|
| Genetic Engineering | 3 | 2019 | 109 | 0.380 |
Why?
|
| MicroRNAs | 3 | 2021 | 622 | 0.370 |
Why?
|
| Gene Editing | 3 | 2021 | 224 | 0.340 |
Why?
|
| Gene Silencing | 2 | 2019 | 357 | 0.320 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 211 | 0.310 |
Why?
|
| HEK293 Cells | 3 | 2022 | 530 | 0.270 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1125 | 0.270 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 22 | 0.270 |
Why?
|
| Humans | 23 | 2022 | 48594 | 0.260 |
Why?
|
| Central Nervous System | 3 | 2020 | 137 | 0.260 |
Why?
|
| DNA, Viral | 3 | 2021 | 241 | 0.250 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 14 | 0.240 |
Why?
|
| Capsid | 2 | 2020 | 72 | 0.240 |
Why?
|
| Genome, Viral | 3 | 2019 | 109 | 0.240 |
Why?
|
| Capsid Proteins | 2 | 2020 | 88 | 0.240 |
Why?
|
| Gene Order | 2 | 2019 | 26 | 0.230 |
Why?
|
| Baculoviridae | 1 | 2022 | 25 | 0.230 |
Why?
|
| Insecta | 1 | 2022 | 35 | 0.230 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 8 | 0.230 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 28 | 0.220 |
Why?
|
| Tyrosinemias | 1 | 2021 | 21 | 0.220 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 7 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 2901 | 0.220 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 27 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 249 | 0.210 |
Why?
|
| Lentivirus | 1 | 2021 | 45 | 0.210 |
Why?
|
| Communicable Diseases | 1 | 2021 | 76 | 0.200 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 897 | 0.200 |
Why?
|
| Cisterna Magna | 1 | 2019 | 10 | 0.200 |
Why?
|
| Bone Resorption | 1 | 2019 | 45 | 0.190 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 41 | 0.190 |
Why?
|
| Ovalbumin | 1 | 2019 | 107 | 0.190 |
Why?
|
| Antigen Presentation | 1 | 2021 | 228 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2021 | 202 | 0.180 |
Why?
|
| Organ Specificity | 1 | 2019 | 175 | 0.180 |
Why?
|
| Macular Degeneration | 1 | 2021 | 155 | 0.180 |
Why?
|
| Genes, Recessive | 1 | 2018 | 50 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2021 | 688 | 0.180 |
Why?
|
| Osteoporosis | 1 | 2019 | 131 | 0.180 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 179 | 0.180 |
Why?
|
| Bone and Bones | 1 | 2019 | 144 | 0.170 |
Why?
|
| Heterozygote | 1 | 2018 | 152 | 0.170 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 24 | 0.170 |
Why?
|
| Gene Ontology | 1 | 2017 | 32 | 0.170 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 13 | 0.170 |
Why?
|
| Computational Biology | 1 | 2019 | 298 | 0.170 |
Why?
|
| Introns | 1 | 2017 | 111 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 694 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2018 | 124 | 0.160 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 85 | 0.160 |
Why?
|
| Transfection | 2 | 2017 | 650 | 0.160 |
Why?
|
| Alleles | 1 | 2018 | 414 | 0.160 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 4 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2063 | 0.150 |
Why?
|
| Alphavirus | 1 | 2015 | 3 | 0.150 |
Why?
|
| Colforsin | 1 | 2015 | 19 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 68 | 0.150 |
Why?
|
| Cell Lineage | 1 | 2017 | 242 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 2015 | 135 | 0.140 |
Why?
|
| Liver | 1 | 2019 | 701 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2014 | 1439 | 0.140 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 594 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 215 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 259 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 110 | 0.130 |
Why?
|
| Luciferases | 1 | 2014 | 105 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2014 | 194 | 0.130 |
Why?
|
| Metalloproteases | 1 | 2013 | 3 | 0.130 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 11 | 0.120 |
Why?
|
| ADAM Proteins | 1 | 2013 | 31 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 530 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1130 | 0.120 |
Why?
|
| Frozen Sections | 1 | 2012 | 14 | 0.110 |
Why?
|
| Brain | 1 | 2019 | 1163 | 0.110 |
Why?
|
| Base Sequence | 1 | 2014 | 1318 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2012 | 126 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 150 | 0.110 |
Why?
|
| Monocytes | 1 | 2013 | 335 | 0.100 |
Why?
|
| Mutation | 1 | 2018 | 2255 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1996 | 0.100 |
Why?
|
| Serogroup | 2 | 2020 | 26 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 604 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 173 | 0.100 |
Why?
|
| Chromatin | 1 | 2014 | 557 | 0.090 |
Why?
|
| Virus Assembly | 2 | 2020 | 51 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2016 | 2730 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 232 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 789 | 0.080 |
Why?
|
| Neoplasms | 1 | 2015 | 985 | 0.080 |
Why?
|
| Myocardium | 1 | 2007 | 191 | 0.070 |
Why?
|
| Binding Sites | 2 | 2021 | 859 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 796 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 373 | 0.060 |
Why?
|
| Mice, Inbred mdx | 1 | 2021 | 10 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1271 | 0.060 |
Why?
|
| Dystrophin | 1 | 2021 | 21 | 0.060 |
Why?
|
| Male | 5 | 2021 | 23091 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2022 | 76 | 0.060 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 34 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 63 | 0.050 |
Why?
|
| Vaccines | 1 | 2021 | 73 | 0.050 |
Why?
|
| Swine | 1 | 2021 | 298 | 0.050 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 84 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 167 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2019 | 38 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 41 | 0.050 |
Why?
|
| Catheters | 1 | 2019 | 53 | 0.050 |
Why?
|
| Cartilage | 1 | 2019 | 25 | 0.050 |
Why?
|
| Sheep | 1 | 2019 | 155 | 0.050 |
Why?
|
| Video Recording | 1 | 2019 | 99 | 0.050 |
Why?
|
| RNA Stability | 1 | 2019 | 88 | 0.050 |
Why?
|
| Phylogeny | 1 | 2020 | 297 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2019 | 109 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 146 | 0.050 |
Why?
|
| Models, Animal | 1 | 2019 | 200 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 155 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 165 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 163 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 10 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 268 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2018 | 21 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 304 | 0.040 |
Why?
|
| Blastocyst | 1 | 2018 | 63 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 238 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 255 | 0.040 |
Why?
|
| Endonucleases | 1 | 2018 | 76 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 849 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 123 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2016 | 28 | 0.040 |
Why?
|
| Response Elements | 1 | 2016 | 37 | 0.040 |
Why?
|
| Plasmids | 1 | 2017 | 271 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 335 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 730 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1926 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2016 | 71 | 0.040 |
Why?
|
| Oncolytic Viruses | 1 | 2015 | 5 | 0.040 |
Why?
|
| Oncolytic Virotherapy | 1 | 2015 | 6 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2019 | 493 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 602 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2015 | 48 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 475 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 38 | 0.040 |
Why?
|
| Female | 3 | 2021 | 26148 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 374 | 0.040 |
Why?
|
| Cytokines | 1 | 2019 | 820 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 56 | 0.040 |
Why?
|
| DNA Replication | 1 | 2017 | 220 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 239 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2016 | 109 | 0.040 |
Why?
|
| Synteny | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1893 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 631 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1062 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 445 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 9 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 16 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2013 | 30 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 33 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 476 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 135 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1799 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1368 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 711 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2013 | 310 | 0.030 |
Why?
|
| COS Cells | 1 | 2012 | 176 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 1125 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 96 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 2016 | 0.030 |
Why?
|
| Proteomics | 1 | 2012 | 199 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 1026 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1534 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1810 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 4 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 38 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 215 | 0.020 |
Why?
|